Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 982 | 2,547 | 701 | 999 | 1,688 |
| Cost of Goods | 35 | 106 | 109 | 54 | 52 |
| Gross Profit | 947 | 2,441 | 592 | 945 | 1,636 |
| Operating Expenses | 11,339 | 11,691 | 12,888 | 10,562 | 11,201 |
| Operating Income | -10,357 | -9,144 | -12,187 | -9,563 | -9,513 |
| Interest Expense | -174 | 0 | 0 | -37 | 10 |
| Other Income | 76,727 | 4,498 | -51,511 | -67,318 | 28,281 |
| Pre-tax Income | 66,544 | -4,646 | -63,698 | -76,844 | 18,758 |
| Income Tax | N/A | N/A | N/A | -4,772 | 4,772 |
| Net Income Continuous | 66,544 | -4,646 | -63,698 | -72,072 | 13,986 |
| Minority Interests | -181 | -431 | -150 | -138 | -335 |
| Net Income | $66,725 | $-4,215 | $-63,548 | $-71,934 | $14,321 |
| EPS Basic Total Ops | 0.53 | -0.03 | -0.50 | -0.64 | 0.12 |
| EPS Basic Continuous Ops | 0.52 | -0.04 | -0.50 | -0.66 | 0.12 |
| EPS Diluted Total Ops | 0.53 | -0.03 | -0.50 | -0.64 | 0.12 |
| EPS Diluted Continuous Ops | 0.52 | -0.04 | -0.50 | -0.65 | 0.12 |
| EBITDA(a) | $-9,552 | $-8,283 | $-11,324 | $-8,537 | $-8,848 |